AVGR: חובות לטווח קצר של החברה Avinger, Inc

Avinger, Inc. (AVGR) develops Pantheris laser catheters for arterial therapy, leveraging the expansion of consumable sales and new FDA clearances. The market trend visualized in monetary terms on GURU.Markets, where the indicator stands at 0.01, highlights the competition for hospital distribution channels. Stable cleanroom operations and packaging automation ensure production reliability for these high-tech devices.

Institutional investors assess the attractiveness of Avinger, Inc. (AVGR) through the lens of liquidity, as a high debt load coupled with the slow implementation of new catheter systems may limit capitalization. By analyzing short-term borrowing levels, we measure the volume of obligations maturing within one year, which, under strict FDA regulations, determines the asset's financial stability and its ability to service debt without external refinancing.